GWPH stock is moving up double-digits after GW Pharmaceuticals (NASDAQ:GWPH) reported a big jump in its cannabis-derived epilepsy drug, Epidiolex.
The medicine uses CBD, and it is known to be an effective treatment for some types of epilepsy.Impressive Quarterly Numbers
As everyone knows, the ultimate aim of many marijuana companies is to manufacture a product that can eventually treat medical conditions, and that ambition received a major boost today after the announcement of GW Pharmaceuticals’ Q2 2019 results. One of the most important products that GW has come up with is a cannabis-based ...
Get the latest marijuana stock news, cannabis on stock news on PotStockNews